Literature DB >> 26607740

Optimized Protocol To Analyze Changes in the Lipidome of Xenografts after Treatment with 2-Hydroxyoleic Acid.

Roberto Fernández1, Jone Garate1, Sergio Lage1, Silvia Terés2, Mónica Higuera3, Joan Bestard-Escalas4, M Laura Martin5, Daniel H López4, Francisca Guardiola-Serrano3, Pablo V Escribá3, Gwendolyn Barceló-Coblijn4, José A Fernández1.   

Abstract

Xenografts are a popular model for the study of the action of new antitumor drugs. However, xenografts are highly heterogeneous structures, and therefore it is sometimes difficult to evaluate the effects of the compounds on tumor metabolism. In this context, imaging mass spectrometry (IMS) may yield the required information, due to its inherent characteristics of sensitivity and spatial resolution. To the best of our knowledge, there is still no clear analysis protocol to properly evaluate the changes between samples due to the treatment. Here we present a protocol for the evaluation of the effect of 2-hydroxyoleic acid (2-OHOA), an antitumor compound, on xenografts lipidome based on IMS. Direct treated/control comparison did not show conclusive results. As we will demonstrate, a more sophisticated protocol was required to evaluate these changes including the following: (1) identification of different areas in the xenograft, (2) classification of these areas (necrotic/viable) to compare similar types of tissues, (3) suppression of the effect of the variation of adduct formation between samples, and (4) normalization of the variables using the standard deviation to eliminate the excessive impact of the stronger peaks in the statistical analysis. In this way, the 36 lipid species that experienced the largest changes between treated and control were identified. Furthermore, incorporation of 2-hydroxyoleic acid to a sphinganine base was also confirmed by MS/MS. Comparison of the changes observed here with previous results obtained with different techniques demonstrates the validity of the protocol.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26607740      PMCID: PMC5017204          DOI: 10.1021/acs.analchem.5b03978

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  55 in total

Review 1.  Mass spectrometric imaging for biomedical tissue analysis.

Authors:  Kamila Chughtai; Ron M A Heeren
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Sublimation as a method of matrix application for mass spectrometric imaging.

Authors:  Joseph A Hankin; Robert M Barkley; Robert C Murphy
Journal:  J Am Soc Mass Spectrom       Date:  2007-06-30       Impact factor: 3.109

Review 3.  Imaging mass spectrometry in neuroscience.

Authors:  Jörg Hanrieder; Nhu T N Phan; Michael E Kurczy; Andrew G Ewing
Journal:  ACS Chem Neurosci       Date:  2013-04-30       Impact factor: 4.418

4.  MALDI-Mass Spectrometric Imaging Revealing Hypoxia-Driven Lipids and Proteins in a Breast Tumor Model.

Authors:  Lu Jiang; Kamila Chughtai; Samuel O Purvine; Zaver M Bhujwalla; Venu Raman; Ljiljana Paša-Tolić; Ron M A Heeren; Kristine Glunde
Journal:  Anal Chem       Date:  2015-06-04       Impact factor: 6.986

5.  Automatic registration of mass spectrometry imaging data sets to the Allen brain atlas.

Authors:  Walid M Abdelmoula; Ricardo J Carreira; Reinald Shyti; Benjamin Balluff; René J M van Zeijl; Else A Tolner; Boudewijn F P Lelieveldt; Arn M J M van den Maagdenberg; Liam A McDonnell; Jouke Dijkstra
Journal:  Anal Chem       Date:  2014-04-02       Impact factor: 6.986

Review 6.  Cellular lipidomics.

Authors:  Gerrit van Meer
Journal:  EMBO J       Date:  2005-09-01       Impact factor: 11.598

7.  Chemo-informatic strategy for imaging mass spectrometry-based hyperspectral profiling of lipid signatures in colorectal cancer.

Authors:  Kirill A Veselkov; Reza Mirnezami; Nicole Strittmatter; Robert D Goldin; James Kinross; Abigail V M Speller; Tigran Abramov; Emrys A Jones; Ara Darzi; Elaine Holmes; Jeremy K Nicholson; Zoltan Takats
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-07       Impact factor: 11.205

8.  Astaxanthin reduces ischemic brain injury in adult rats.

Authors:  Hui Shen; Chi-Chung Kuo; Jenny Chou; Alice Delvolve; Shelley N Jackson; Jeremy Post; Amina S Woods; Barry J Hoffer; Yun Wang; Brandon K Harvey
Journal:  FASEB J       Date:  2009-02-13       Impact factor: 5.191

9.  Toward digital staining using imaging mass spectrometry and random forests.

Authors:  Michael Hanselmann; Ullrich Köthe; Marc Kirchner; Bernhard Y Renard; Erika R Amstalden; Kristine Glunde; Ron M A Heeren; Fred A Hamprecht
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

10.  Mass spectrometry coupled to imaging techniques: the better the view the greater the challenge.

Authors:  Gwendolyn Barceló-Coblijn; José A Fernández
Journal:  Front Physiol       Date:  2015-01-22       Impact factor: 4.566

View more
  2 in total

1.  2-Hydroxy-oleic acid does not activate sphingomyelin synthase activity.

Authors:  Bin Lou; Qi Liu; Jiahui Hou; Inamul Kabir; Peipei Liu; Tingbo Ding; Jibin Dong; Mingguang Mo; Deyong Ye; Yang Chen; Hai H Bui; Kenneth Roth; Yu Cao; Xian-Cheng Jiang
Journal:  J Biol Chem       Date:  2018-10-10       Impact factor: 5.157

2.  A Drastic Shift in Lipid Adducts in Colon Cancer Detected by MALDI-IMS Exposes Alterations in Specific K+ Channels.

Authors:  Jone Garate; Albert Maimó-Barceló; Joan Bestard-Escalas; Roberto Fernández; Karim Pérez-Romero; Marco A Martínez; Mª Antònia Payeras; Daniel H Lopez; José Andrés Fernández; Gwendolyn Barceló-Coblijn
Journal:  Cancers (Basel)       Date:  2021-03-17       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.